Regeneration in Movement Disorders
21 – 30 of 138
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine
2024) 17 th Congress of the European Haadache Federation(
- Contribution to conference › Poster
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
(
- Contribution to journal › Article
- 2023
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
(
- Contribution to journal › Article
-
Mark
Real-world effectiveness of fremanezumab for the preventive treatment of migraine : Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
(
- Contribution to journal › Article
-
Mark
Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells
(
- Contribution to journal › Article
-
Mark
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms
(
- Contribution to journal › Article
-
Mark
A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies : which parameters better represent the efficacy?
(
- Contribution to journal › Article
-
Mark
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
(
- Contribution to journal › Article